Alternative dosing schedules for methylation inhibitors in MDS treatment.
Frame
David
D
University of Michigan Comprehensive Cancer Center, Ann Arbor, USA.
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077209:Decitabine; D004334:Drug Administration Schedule; D006801:Humans; D008745:Methylation / Q000187:drug effects*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine